Live Analyst Rating Changes 24959 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jack Slevin
JEF

Jack Slevin

Jefferies
Wall Street Analyst
★★★★★
#276
on 13Foresight · ranked by our own returns
75%
Success Rate
+57.8%
Average Return
9 of 12 calls profitable · +47.7% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 75% of Jack Slevin's ratings turned a profit when each position was held for 1 year — averaging +57.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

12 Buy 1 Hold 0 Sell
Jack's Stock Coverage 10 ratings · 2026-08-16
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
AHCO
AdaptHealth
 Jul 21, 2026 BUY Strong Buy
+104.6% avg upside
13 analysts
$13.00
123.79% Upside
 -48.2% ·
LFST
Lifestance Health Group
 Jul 16, 2026 BUY Strong Buy
-6.0% avg upside
15 analysts
$14.00
12.63% Upside
 +10.0% ·
CVSA
Covista
 Jun 30, 2026 BUY Strong Buy
-10.2% avg upside
8 analysts
$175.00
32.65% Upside
 +5.9% ·
ASTH
Astrana Health
 Jun 30, 2026 BUY Strong Buy
+42.5% avg upside
16 analysts
$53.00
29.91% Upside
 -12.1% ·
AGL
Agilon Health
 May 07, 2026 BUY Buy
-31.1% avg upside
26 analysts
$48.00
50.53% Downside
 +53.1% ·
MD
Pediatrix Medical Group
 Apr 20, 2026 BUY Buy
-15.9% avg upside
14 analysts
$27.00
1.48% Upside
 +14.8% ·
USPH
US Physical Therapy
 Mar 09, 2026 BUY Strong Buy
+13.3% avg upside
12 analysts
$102.00
25.54% Upside
 +0.5% ·
PRVA
Privia Health Group
 Feb 26, 2026 BUY Strong Buy
+45.3% avg upside
26 analysts
$32.00
45.54% Upside
 -11.7% ·
AMN
AMN Healthcare Services
 Aug 13, 2025 HOLD Buy
+29.5% avg upside
14 analysts
$21.00
39.11% Downside
 +85.0% ·
STLN
Starling Oncology Institute
 Jun 10, 2024 BUY Strong Buy
+9.7% avg upside
7 analysts
$2.00
68.90% Downside
 +491.1% ·
🔒 5 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Jack Slevin — Frequently Asked Questions
How accurate are Jack Slevin's stock ratings?
Based on the calls 13Foresight could measure, about 75% of Jack's ratings were profitable over a one-year hold, with an average return of +57.8% per rating, or +47.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Jack ranked on 13Foresight?
Jack Slevin is currently ranked #276 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jack cover?
Jack most recently has ratings on AHCO, LFST, CVSA, ASTH, AGL, MD, USPH, PRVA, AMN, STLN. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.